38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association between midlife vascular risk factors and estimated brain amyloid deposition

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Importance

          Midlife vascular risk factors have been associated with late-life dementia; whether these risk factors directly contribute to brain amyloid deposition is less well understood.

          Objective

          To determine if midlife vascular risk factors are associated with late-life brain amyloid deposition, measured using florbetapir positron emission tomography (PET).

          Design, Setting, and Participants

          Prospective cohort study in 3 U.S. communities (Washington County, MD; Forsyth County, NC; and Jackson, MS). 346 participants without dementia in the Atherosclerosis Risk in Communities (ARIC)-PET Amyloid Imaging Study; evaluation of vascular risk factors and markers since 1987-1989, with florbetapir PET scans (2011-2013).

          Exposures

          Vascular risk factors at ARIC baseline (ages 45-64) were evaluated in multivariable models including age, sex, race, APOE genotype, and educational level.

          Outcome

          Standardized Uptake Value Ratios (SUVR) were calculated from PET scans; a mean global cortical SUVR was calculated. Elevated florbetapir (defined at SUVR>1.2) was the dependent variable.

          Results

          In 322 participants without dementia and with nonmissing midlife vascular risk factors at baseline (43% black, 58% female, mean age 52), SUVR (positive in 164 (50.9%) of participants) was measured >20 years later (median followup 23.5; IQR 23.0-24.3) when participants were 67-88 (mean 76 y). Elevated body mass index midlife (BMI) was associated with elevated SUVR (OR 2.06, 95% CI 1.16, 3.65). At baseline, 65 participants had no vascular risk factors, 123 had one, and 134 had two or more; a higher number of midlife risk factors was associated with elevated amyloid SUVR at followup, 30.8% (n=20), 50.4% (n=62), and 61.2% (n=82), respectively. In adjusted models, compared to 0 midlife vascular risk factors, the odds ratio for elevated SUVR associated with 1 vascular risk factor was 1.88 (95% CI 0.95-3.72) and was 2.88 (95% CI 1.46-5.69) for 2 or more vascular risk factors No significant race by risk factor interactions were found. Late-life vascular risk factors were not associated with late-life brain amyloid: (2 or more late-life vascular risk factors compared to 0: OR 1.66, 95% CI 0.75-3.69).

          Conclusions and Relevance

          An increasing number of midlife vascular risk factors was significantly associated with elevated amyloid SUVR; this association was not significant for late-life risk factors. These findings are consistent with a role of vascular disease in the development of Alzheimer’s Disease.

          Related collections

          Author and article information

          Journal
          7501160
          5346
          JAMA
          JAMA
          JAMA
          0098-7484
          1538-3598
          19 March 2018
          11 April 2017
          27 April 2018
          : 317
          : 14
          : 1443-1450
          Affiliations
          [1 ]Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD
          [2 ]Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
          [3 ]Department of Radiology, Section of High Resolution Brain PET Imaging, Johns Hopkins University School of Medicine, Baltimore, MD
          [4 ]Department of Radiology, University of Mississippi Medical Center, Jackson, MS
          [5 ]Hagerstown Imaging, Hagerstown, MD
          [6 ]Department of Neurology, Mayo Clinic, Rochester, MN
          [7 ]Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC
          [8 ]Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC
          [9 ]Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD
          [10 ]Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD
          [11 ]Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
          [12 ]Department of Medicine, University of Mississippi Medical Center, Jackson, MS
          Author notes
          Corresponding Author: Rebecca F. Gottesman, MD PhD; Phipps 446D; 600 North Wolfe Street; Baltimore, MD; Fax 410-614-9807; Phone 410-614-2381; rgottesm@ 123456jhmi.edu
          Article
          PMC5921896 PMC5921896 5921896 nihpa951989
          10.1001/jama.2017.3090
          5921896
          28399252
          67b26f95-1acb-4c1c-92f9-b8c57e8db05f
          History
          Categories
          Article

          dementia,amyloid,hypertension,epidemiology
          dementia, amyloid, hypertension, epidemiology

          Comments

          Comment on this article